Boston Scientific Corporation
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
IN
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Boston Scientific Corporation in real time with a live news feed covering Boston Scientific Corporation stock news, official press releases, company announcements, and an archive of historical Boston Scientific Corporation news. ...more
Loading news...
Loading more...
10:16 AM | Friday | May 29, 2026
Sign in to download news snippet
Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.
Read full articleNo data available for this time period.
Change the time range to see results.
Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.
Read full article
Sales of a key product line will likely be flat this quarter and next, company management said.
Read full article
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Read full article
Pre-Market Stock Futures: Futures are trading lower on Thursday as new records are set almost daily, with the AI/Data center trade continuing to push stocks higher on Wednesday. All four major indices hit or closed Wednesday's session at record highs, with the legacy Dow Jones Industrial Average leading the way, up 0.36% at 50,664, setting...
Here Are Thursday's Top Wall Street Analyst Research Calls: Agilent, Boston Scientific, Comfort Systems, Dick's Sporting Goods, Dominion Energy, Electronic Arts, First Solar, Trade Desk, Valvoline, and More
The Bank of N.T. Butterfield and Son Limited (âButterfieldâ) (NYSE: NTB | BSX: NTB.BH) has entered into a definitive agreement to acquire CIBC's 91.7% intere
Read full article
On May 27, 2026, we delve into the DCF analysis for Boston Scientific Corp (BSX), a company currently facing significant price performance challenges. Over the
Read full article
WATCHMAN's 19% growth and trial wins bolster Boston Scientific's push to expand its addressable market from 5M to 20M patients worldwide.
Read full article
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
Read full article
TORONTO, May 21, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX, OTCQX: BSXGF) is pleased to provide an update regarding hearings held yesterday before the 6th Panel of the Federal Regional Court of the 1st Region (“TRF-1”) in relation to three judicial proceedings involving the Volta Grande Gold Project (the “Project”), located in Pará State, Brazil. DPU Appeal Dismissed One of the matters heard concerned the appeal filed by the Federal Public Defender's Office (“DPU”) and an indigenous association against a lower court decision that had dismissed for procedural reasons a civil public action related to the alleged need for supplementation of the Indigenous Component Study (“ECI”) and the performance of additional public consultation procedures.
Read full article
Boston Scientific Corporation (NYSE:BSX) on Tuesday reported positive pivotal trial data for its investigational SEISMIQ 4CE Coronary Intravascular Lithotripsy catheter, with the device meeting both primary safety and effectiveness goals in patients with severely calcified coronary artery disease.
Read full article
No data available for this time period.
Change the time range to see results.